The Data Standards Strategy reinforces CDER’s ongoing commitment to the development, implementation, and maintenance of a comprehensive data standards program that will facilitate the efficient and effective review of regulatory submissions. This helps bring safe and effective products to market.
Similar Posts
Velocity Pharma LLC – 676434 – 07/17/2024
CGMP/Finished Pharmaceuticals/AdulteratedFDA/MHRA/Health Canada Symposium: Regulatory perspectives in good clinical practice, bioequivalence and good pharmacovigilance practice – 06/02/2026
This symposium will highlight current and emerging topics of interest to the industry related to good clinical practice, bioequivalence and good pharmacovigilance practice.CDER Small Business and Industry Assistance (SBIA) Learn
SBIA Learn offers a variety of multimedia resources to provide information that is comprehensive, interactive, and easily accessible to small pharmaceutical business and industry.DeVere Manufacturing Inc. – 715846 – 11/12/2025
CGMP/Finished Pharmaceuticals/AdulteratedTan-Alize Kozmetick ve Temizlik Urunleri Sanayi ve Ticaret A.S. – 659854 – 08/14/2024
CGMP/Finished Pharmaceuticals/AdulteratedInformation for Consumers and Patients | Drugs
Drug Information for Patients and Consumers